Biocon’s arm receives Rs 536 crore subscription money from Activ Pine LLP

22 Jan 2020 Evaluate

Biocon’s wholly owned subsidiary--- Biocon Biologics India (BBIL) has received the subscription money aggregating to Rs 536.25 crore from Activ Pine LLP (an affiliate of True North Fund VI LLP). Consequently, the Board of BBIL has approved the allotment of 50,25,463 equity shares of Rs 10 each at a price of Rs 1,067.07 per equity share (including a premium of Rs. 1,057.07 per equity share) to Activ Pine LLP. Earlier, Biocon, BBIL and Activ Pine LLP have executed a share subscription agreement and a shareholder agreement. 

Biocon is India’s largest and Asia’s leading Biotechnology Company with a strategic focus on biopharmaceuticals and research services. It is a fully integrated, innovation-driven biopharma enterprise offering affordable solutions for chronic diseases to patient's worldwide.

Biocon Share Price

368.00 2.75 (0.75%)
28-Jan-2026 14:25 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1606.35
Dr. Reddys Lab 1221.90
Cipla 1321.50
Zydus Lifesciences 891.30
Lupin 2126.70
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×